![](/img/cover-not-exists.png)
An Open-Label, Single-Arm, Phase 1 Study to Assess Biomarker Effects, Efficacy, and Safety of Ofatumumab in Patients With Refractory Chronic Lymphocytic Leukemia
Patton, William Nigel, Lindeman, Robert, Butler, Andrew C., Kipps, Thomas J., Jewell, Roxanne C., Laubscher, Kevin H., Zhou, YanYan, Lewis, Eric, Sedoti, Donna, Witman, Philip, Fang, Lei, Chan, GeoffrLanguage:
english
Journal:
Leukemia & Lymphoma
DOI:
10.3109/10428194.2015.1014357
Date:
February, 2015
File:
PDF, 1.04 MB
english, 2015